Contact Us
EU MDR Clinical Evaluation of Medical Devices
EU MDR Clinical Evaluation for Medical device is a mandatory, systematic process required under EU MDR 2017/745, Article 61 for every device seeking CE Marking in Europe. Manufacturers must continuously collect, appraise, and analyze clinical data to demonstrate that the device is safe, performs as intended, and delivers measurable clinical benefit to patients.
Under Article 61 and Annex XIV Part A, this requirement applies to all device classes  starting from Class I through Class III and must be maintained and updated throughout the product lifecycle. An MDR compliant clinical evaluation provides the scientific evidence needed to demonstrate conformity with the General Safety and Performance Requirements (GSPRs), supporting Notified Body approval and reducing the risk of non-conformities during surveillance audits.
At I3CGlobal, our team of consultants, medical writers delivers end-to-end MDR clinical evaluation documentation that is fully aligned with MEDDEV 2.7/1 Rev. 4, EU MDR Annex XIV, and current MDCG guidance for manufacturers of all sizes seeking European market access.
When is Medical Device Clinical Evaluation Required?
Key Features of our Medical Device Clinical Evaluation Service
European Regulatory Framework for Medical Devices Clinical Evaluation
Medical device clinical evaluation within the European regulatory framework is governed primarily by EU MDR 2017/745, which replaced the earlier Medical Device Directive (MDD 93/42/EEC). Unlike the MDD, which allowed manufacturers to rely heavily on literature data with minimal scrutiny, the MDR introduced significantly stricter expectations for clinical evidence making robust clinical evaluation a non-negotiable requirement for all device classes seeking CE Marking.
MDR Article 61 — Clinical Evaluation Requirements
MDR Article 61 establishes the legal basis for Clinical Evaluation and requires manufacturers to:
- Plan, conduct, and document Clinical Evaluation within Technical Documentation
- Demonstrate conformity with General Safety and Performance Requirements (GSPRs) using clinical data
- Maintain Clinical Evaluation as an ongoing lifecycle process supported by PMS and PMCF activities
For Class III and implantable Class IIb devices, clinical investigations are generally expected unless sufficient clinical evidence and equivalence justification are available.
MDR Annex XIV and CER
Annex XIV Part A defines the framework for preparing a Clinical Evaluation Plan (CEP), systematic literature review, clinical data appraisal, and the Clinical Evaluation Report (CER). Annex XIV Part B establishes Post-Market Clinical Follow-Up (PMCF) requirements to ensure continuous clinical evidence generation after CE Marking.
MEDDEV 2.7/1 Rev 4 Guidance
MEDDEV 2.7/1 Rev 4 remains the primary guidance document used by Notified Bodies for assessing CER quality under MDR. It defines expectations for:
- Clinical Evaluator qualifications
- Literature search methodology
- Equivalence justification
- State of the Art analysis
- Risk-benefit assessment linked to ISO 14971
The guidance also supports compliance with MDCG 2020-13, MDCG 2020-7, and MDCG 2021-6 clinical evaluation expectations.
Start Your Medical Device Clinical Evaluation Today
Whether you are preparing a new MDR CE Marking application, transitioning a legacy MDD device, or need annual CER updates. I3CGlobal’s clinical evaluation team is ready to support you. We accept all device risk classes and work with manufacturers in over 50 countries.
EU MDR Clinical Evaluation Documentation
In the new medical device regulation MDR 2017/745 all manufacturers have to face the monumental task of updating EU MDR clinical evaluation documentation for their entire product portfolio. This task must be completed before they provide technical documentation which includes the Clinical evaluation report to notified bodies for CE Certification.
It is understood from the enquires we receive every day across the Globe, that 60% of device manufacturers told us they have no strategy in place to remediate gaps in their clinical documentation or so far no process in place for literature search, EU MDR Clinical evaluation report planning, data collection, etc., which are the essential elements of medical device CE compliance under the new MDR from May 2021.
Either during the MDR transition or new medical device CE Marking application with Notified Bodies, there continues to be confusion about these requirements laid down in MDR 2017/745 article 61 worrying for manufacturers as it holds up the compliance process.
Essential Clinical Evaluation Documents for Successful Technical Documentation Approval
EU MDR Clinical evaluation is a key component of the technical documentation file. It is required for several reasons:
- It determines the scientific validity of the device by examining clinical data from multiple sources, such as clinical evaluation, published literature, post-market surveillance, and post market clinical follow up. This ensures that the device’s safety, performance, and clinical benefit claims are supported by solid, documented evidence.
- Clinical evaluation and risk management are closely interrelated. Risk management identifies, evaluates, and mitigates potential risks, while evaluation helps estimate the device’s risk benefit profile, guiding decisions on patient safety and risk management strategies.
- MDR Article 61 emphasizes ongoing evaluation through post-market surveillance (PMS) and Post-Market Clinical Follow-up (PMCF). Continuous monitoring identifies new risks and ensures that the device remains safe and effective throughout its lifecycle.
- The evaluation must demonstrate that the device is safe and effective for the intended user population and clinical indications, reducing the likelihood of adverse events or ineffective treatment in real-world use.
- It must provide a detailed justification of equivalence/similarity, comparing the technical, biological, and clinical characteristics of equivalent devices. This ensures that clinical data from equivalent devices can be reliably applied.
- The findings guide decisions on device labeling, instructions for use, contraindications, and precautions, and help Notified Bodies assess whether the device should be approved for market entry or continued use.
- A well-conducted evaluation enhances transparency, giving healthcare professionals, patients, and Notified Bodies confidence in the device’s performance and safety.
At I3CGLOBAL, our team of doctors, dentists, nurses, regulatory professionals, and clinical evaluation report writers provides end-to-end solutions for medical device manufacturers of all sizes interested in MDR CE Mark certification. We ensure compliance with MDR Article 61 and MEDDEV 2.7/1 Rev. 4, helping your documentation meet the expectations of different Notified Bodies.
Our Step by Step Medical Device Clinical Evaluation Writing Process
| Stage | Items | What We Do |
|---|---|---|
| 1 | Scope & CEP | Define device, intended purpose, risk class, equivalent devices, and regulatory history. Prepare the Clinical Evaluation Plan (CEP). |
| 2 | State of the Art | Map current clinical technologies, practices, and available alternatives to establish the benchmark your device must meet. |
| 3 | Literature Search | Perform systematic searches across PubMed, Embase, Cochrane, and other databases using defined PICO criteria and inclusion/exclusion filters. |
| 4 | Data Appraisal | Appraise clinical data for scientific validity, relevance, and quality using MEDDEV Appendix C & D grading criteria. |
| 5 | Equivalence | Demonstrate technical, biological, and clinical equivalence to predicate devices under MDCG 2020-5 where applicable. |
| 6 | Data Analysis | Synthesize positive and negative evidence to evaluate safety, performance, side-effect acceptability, and risk-benefit profile. |
| 7 | CER Writing | Prepare a complete Clinical Evaluation Report (CER) ready for Notified Body technical documentation review. |
| 8 | PMCF Plan | Define Post-Market Clinical Follow-Up activities to close clinical evidence gaps and support ongoing CER updates. |
| 9 | Annual Updates | Monitor PMS data, clinical findings, and regulatory changes to maintain updated CER documentation throughout the device lifecycle. |
EU MDR Article 61 Requirements for Medical Device Clinical Evaluation
| Requirement | What It Means in Practice |
|---|---|
| Clinical Evaluation Plan (CEP) | Written plan defining scope, methodology, device description, and evaluation schedule. All are required before the process starts |
| Systematic Literature Review | Structured database search (PubMed, Embase, Cochrane) for clinical data on the device and equivalent devices |
| Clinical Data Appraisal | Assessment of every data source for scientific validity, relevance, and quality per MEDDEV 2.7/1 Rev.4 Appendix C & D |
| Clinical Evaluation Report (CER) | Complete, stand-alone report documenting all clinical evidence, risk-benefit analysis, and conclusions |
| PMCF Plan | Post Market Clinical Follow Up plan to collect ongoing real-world evidence and feed it back into the next CER update |
| Periodic CER Updates | Annual updates and few every 2–5 years. If sooner by new safety data or device changes |
MEDDEV 2.7/1 Rev.4 : The Framework for Medical Devices Clinical Evaluation
MEDDEV 2.7/1 Rev.4 is the primary guidance document governing eu mdr clinical evaluation. Every CER produced by I3CGlobal is structured around its requirements:
| MEDDEV Clause | What It Governs |
|---|---|
| Clause 6.2.3 | Minimum frequency of CER review and update defined by device risk class |
| Clause 6.4 | Qualification requirements for clinical evaluators expertise, independence, and conflict of interest rules |
| Section 7 + Appendix 5 | Safety, clinical performance, and risk-benefit endpoints the CER must address and conclude on |
| Clause 8.2 | State of the Art definition — how to benchmark the device against current medical practice and available alternatives |
| Sections 8–10, App 5–7 | Scientific validity — criteria for assessing relevance, reliability, and weighting of clinical datasets |
| Appendix 1 | Equivalence justification — detailed requirements for demonstrating biological, technical, and clinical similarity to predicate devices |
| Appendix 7.2 | Risk-benefit assessment — framework for evaluating clinical risks against benefits and acceptability of side effects |
| Appendix 12 | Notified Body assessment criteria — what NB reviewers look for and how they assess submitted CERs |
Clinical Evaluation Requirements for Legacy and MDD to MDR Transitioning Devices
Manufacturers with devices previously CE marked under MDD face a common and urgent challenge: existing clinical documentation is almost always insufficient for MDR clinical evaluation standards. I3CGlobal conducts a structured clinical data gap analysis to identify exactly what additional evidence is needed then builds a targeted remediation plan to avoid unnecessary clinical investigations wherever possible.
We help you determine whether equivalence-based documentation is defensible for your device class and risk profile, and whether the Article 61(10) route is genuinely available or whether building new clinical evidence is the safer, faster path to Notified Body approval.
Do you need an email containing full details within 2 minutes? Privacy Policy>>
MDD vs MDR Clinical Evaluation
The requirement to perform an Evaluation found in part I of Annex X of the Medical Device Directive (MDD) is inadequate with the expectations. Therefore, the EU authorities published a guidance document Meddev 2.7.1 rev 4Â Guide for manufacturers and notified bodies.
In EU MDR Clinical Evaluation, the requirements can be found in Article 61 and Part A of Annex XIV. Part A is focused on the pre-market phase and is an extension of part I of MDD Annex X. While the evaluation is still less detailed than the current Meddev 2.7/1 rev 4Â it states the requirement of (a) CEP (b) Evaluation of clinical data and (c) CER.
Frequently Asked Questions: EU MDR Clinical Evaluation Of Medical Devices
When to update EU MDR Clinical Evaluation Documents
EU MDR Clinical evaluation and safety check is a continuous process besides, (a) Change in device State of Art (b) Change in components (c) Annual Updates
Who is a CER Consultant? Can the consultant be an “Evaluator”?
EU MDR Clinical evaluation consultant is an expert in regulation but not an expert in interpreting the clinical significance of the device. A Clinical Evaluator is the person (or persons) who is ultimately responsible to appraise and analyze the clinical data and consultant determine whether it is sufficient to demonstrate compliance with regulation and Notified Body requirements. An evaluator should be a suitably qualified individual who can annoyingly make final judgements about the data collected.
If I don't have access to a competitor's technical / clinical data, how can I demonstrate equivalence?
Manufacturer will need to have sufficient data to prove biological, technical, and clinical equivalence by way of bench testing reports, competitor’s labeling and IFU where many information that can be used to substantiate equivalence; indications, patient population treated, design characteristics, general device specifications, surgical technique, principles of operation, and constructional materials used. Harmonized and Non harmonized standards can often be used to substantiate testing specifications, such as biocompatibility and performance testing. Therefore, even you do not have access to a competitor technical documentation information in the public domain will help to large extend.
How can I verify EU MDR Clinical evaluation documents are correct?
We offer a free tool made in line with the latest MDR. Customers can browse the page and take a trial to find the GAPS.
Is Meddev 2.7.1 Rev 4, to be followed for Class I Devices?
Yes, its mandatory. No matter what the device risk class and what for it is used.
Current regulations applicable for medical device Clinical Evaluation Documentation
Page updated on 11th May 2026 by Sara Moly. Approved by Asha Johnson